Euretina Logo, Links to homepage.
Euretina Logo, Links to homepage.
  • Events
    • Euretina 2026 Vienna
      • Welcome
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
        • Wet Labs
        • WSPOS X EURETINA Paediatric Retina Day
        • World Retina @ Euretina
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Abstract Submission
      • Session Submission
      • General Information
        • FAQs
        • Social Media Toolkit
        • Delegate Party
        • Sustainability Plan
        • Meeting Policy
        • Travel Details
    • Euretina Innovation Spotlight (EIS) 2026
      • General Information
      • Registration
      • Programme
      • Contributors
      • Companies
      • Application for Emerging Companies
    • EuretinaAI: AI in Retina
    • Special Focus Meeting 2027 – Inherited Retinal Diseases
    • Special Focus Meeting 2026 – AI in Retina
      • Registration
      • Post-Event Hub
      • Hotels
      • Programme
      • Keynote
      • Poster Submission
    • Euretina 2025 Paris
      • 2025 Paris On Demand
      • Welcome
      • Congress Daily & Photo Gallery
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
      • Abstracts
      • Satellite Symposia
      • Abstract Submission
      • Late Breaking Submissions
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Euretina Innovation Spotlight (EIS)
      • General Information
        • Sustainability Plan
        • Travel Details
        • Delegate Party
        • Women in Retina Networking Breakfast
        • 2025 Press
        • Social Media Toolkit
    • Special Focus Meeting 2025 – Ocular Endotamponades
      • About
      • Programme
      • Poster & Video Presentations
    • Future Meetings
    • Upcoming Digital Events
  • Free Resources
    • Webinars
    • Podcasts
    • Case Club Cases
    • Euretina Guidelines
    • Euretina Brief
    • IME ePlatform
  • Membership
  • About
    • Euretina Board
    • Committees
    • Subspecialty Sections
    • Code of Conduct
    • Bye-laws
    • Our Sustainability Commitment
    • 25th Anniversary
      • Euretina Congresses 2001-2025
      • A History of Euretina
  • Opportunities
    • Ramin Tadayoni Award 2026
    • Mentorship Programme 2026
      • Mentorship Alumni
    • Jacqueline Cigrang AMD Research Grant
    • Observership Grant Programme 2026
    • RMCR Award Programme 2026
    • EBO-Euretina Exam 2026
    • YOURS
      • Ophthalmologica Lecturer 2026 Proposal
    • Women in Retina
      • Overview
      • Women in Retina Committee
      • Women in Retina Survey 2026
      • Women in Retina Networking Breakfast 2026
      • Women in Retina Networking Breakfast 2025
      • Interview with Anat Loewenstein
      • Women in Retina Interviews 2025
      • Women in Retina Interviews 2023
      • Euretina White Paper on Gender Diversity
      • Euretina Survey on Gender Diversity
    • BEAVRS VR Database
    • CME Credits
  • Member Login
  • Events
    • Euretina 2026 Vienna
      • Welcome
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
        • Wet Labs
        • WSPOS X EURETINA Paediatric Retina Day
        • World Retina @ Euretina
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Abstract Submission
      • Session Submission
      • General Information
        • FAQs
        • Social Media Toolkit
        • Delegate Party
        • Sustainability Plan
        • Meeting Policy
        • Travel Details
    • Euretina Innovation Spotlight (EIS) 2026
      • General Information
      • Registration
      • Programme
      • Contributors
      • Companies
      • Application for Emerging Companies
    • EuretinaAI: AI in Retina
    • Special Focus Meeting 2027 – Inherited Retinal Diseases
    • Special Focus Meeting 2026 – AI in Retina
      • Registration
      • Post-Event Hub
      • Hotels
      • Programme
      • Keynote
      • Poster Submission
    • Euretina 2025 Paris
      • 2025 Paris On Demand
      • Welcome
      • Congress Daily & Photo Gallery
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
      • Abstracts
      • Satellite Symposia
      • Abstract Submission
      • Late Breaking Submissions
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Euretina Innovation Spotlight (EIS)
      • General Information
        • Sustainability Plan
        • Travel Details
        • Delegate Party
        • Women in Retina Networking Breakfast
        • 2025 Press
        • Social Media Toolkit
    • Special Focus Meeting 2025 – Ocular Endotamponades
      • About
      • Programme
      • Poster & Video Presentations
    • Future Meetings
    • Upcoming Digital Events
  • Free Resources
    • Webinars
    • Podcasts
    • Case Club Cases
    • Euretina Guidelines
    • Euretina Brief
    • IME ePlatform
  • Membership
  • About
    • Euretina Board
    • Committees
    • Subspecialty Sections
    • Code of Conduct
    • Bye-laws
    • Our Sustainability Commitment
    • 25th Anniversary
      • Euretina Congresses 2001-2025
      • A History of Euretina
  • Opportunities
    • Ramin Tadayoni Award 2026
    • Mentorship Programme 2026
      • Mentorship Alumni
    • Jacqueline Cigrang AMD Research Grant
    • Observership Grant Programme 2026
    • RMCR Award Programme 2026
    • EBO-Euretina Exam 2026
    • YOURS
      • Ophthalmologica Lecturer 2026 Proposal
    • Women in Retina
      • Overview
      • Women in Retina Committee
      • Women in Retina Survey 2026
      • Women in Retina Networking Breakfast 2026
      • Women in Retina Networking Breakfast 2025
      • Interview with Anat Loewenstein
      • Women in Retina Interviews 2025
      • Women in Retina Interviews 2023
      • Euretina White Paper on Gender Diversity
      • Euretina Survey on Gender Diversity
    • BEAVRS VR Database
    • CME Credits
  • Member Login
  • September 10, 2021
  • 2021 Abstracts

En Face OCT analysis of Paracentral Acute Middle Maculopathy (PAMM)

Author: ISABEL SENDINO-TENORIO (Spain)

Co-authors: Carlos Plaza-Laguardia, Amancia Mateos-Hernández, Laura Monje-Fernández, Felipe Costales-Mier, Esteban Pertejo-Fernandez, Borja Errazquin-Aguirre

Purpose

To describe the pathological findings in the optical coherence tomography (OCT) images using high segmentation technology such as the En Face mode or the OCT – Angiography (OCT – A).

Setting/Venue

Complejo Asistencial Universitario de León.

Methods

Case report.

Results

A 47-year-old caucasian woman presented with acute central scotoma in her left eye (OS) of 7 hours of evolution without other symptoms. Her best corrected visual acuity (BCVA) was 20/20 in the right eye (OD) and 20/70 in the OS. The OCT showed an hyper-reflective lesion in the inner nuclear layer (INL) and the outer plexiform layer (OPL). An identical shaped area was found in the OCT En Face analysis: an hyper-reflective zone in the middle retinal layers and hypo-reflective in the ellipsoid segmentation. In the OCT – A we found the hypo-reflective perifoveal area at the DCP level. Two and a half months later her BVCA was 20/20 with complete subjective resolution of the clinical process. The improvement was remarkable in the complementary tests with resolution of the ischemic area in the funduscopy, the disappearance of the hyperreflective area in the structural OCT (although a slight thinning of the internal layers was observed), and the resolution of the abnormalities in the En Face segmentation. A visual field test was performed to detect possible residual scotoma, however apparently the recovery was complete.

Conlusions

The En Face OCT technology, although it was initially described in 2006, has experienced a growth in its clinical use in recent times. Instead of employing high-resolution cross-sectional scans, En Face analysis allows the physician to enjoy c-scan images in the coronal plane thanks to the cubic image obtained by a dense raster scan. The advantages of this technology include the ability to locate lesions with great precision in the different layers of the retina using the axial distribution of cross sections and tracking systems that use retinal vessels and other reference points. The role that En face OCT has played in the study of PAMM has made it possible to differentiate 3 types of lesions based on the pathogenetic mechanism of microvascular ischemia of the retina. Our patient presented a fern-like pattern in the context of a PAMM with associated venous occlusion, so it is assumed that an increase of the intraluminal hydrostatic pressure was transmitted from the obstruction to the venous drainage area, which clinically translated into a wide zone of parafoveal retinal whitening and an acute onset paracentral scotoma. The visual prognosis of PAMM is usually good. To date, the majority of bibliographic publications report patients with partial recovery of the scotoma in the visual field, as well as stable retinal changes during the months following the acute phase. These changes are atrophy with attenuation of INL and OPL. On the other hand, although complete campimetric recovery is very infrequent, significant visual sequelae are extremely rare. Masaki Nakamura et al described a case that presented a serous retinal detachment in the fourth year of the follow-up of an hypertensive patient without associated ophthalmological pathology. Our patient presented a surprising visual recovery, in the absence of microperimetry in our center, which was observed by visual field analysis two and a half months after the clinical onset. The rise of new tomographic imaging techniques of the retina has dramatically increased the number of cases described in the literature of patients with PAMM. The physiopathogenesis, deduced thanks to the patterns obtained in the En Face OCT, suggests that within all the possible mechanisms and given the good evolution of the case, the transitory occlusion of the venous drainage of the ischemic area may be the reason for the fast and complete improvement, and therefore maybe this mechanism represents the one that offers the best prognosis as long as the venous flow remains altered for a short period of time.

Financial Disclosure

No

Comments

-
PrevPrevious
NextNext
Euretina Logo, Links to homepage.

Secretariat Address
European Society of Retina Specialists
Reinacherstrasse 131
4053 Basel
Switzerland

T +41 61 686 77 91
F +41 61 686 77 88

Email: [email protected]

Euretina 2026 Vienna

Ophthalmologica

Forum

Opportunities

Memberships

About

Code of Conduct

Privacy Policy

Contact Us

Euretina 2026 Vienna

Ophthalmologica

Forum

Opportunities

Memberships

About

Code of Conduct

Privacy Policy

Contact Us

Newsletter Sign up

By clicking 'Subscribe', you agree to the terms of our Privacy Policy. 
 
 

Follow us

© EURETINA 2026 All rights reserved

  • Events
    • Euretina 2026 Vienna
      • Welcome
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
        • Wet Labs
        • WSPOS X EURETINA Paediatric Retina Day
        • World Retina @ Euretina
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Abstract Submission
      • Session Submission
      • General Information
        • FAQs
        • Social Media Toolkit
        • Delegate Party
        • Sustainability Plan
        • Meeting Policy
        • Travel Details
    • Euretina Innovation Spotlight (EIS) 2026
      • General Information
      • Registration
      • Programme
      • Contributors
      • Companies
      • Application for Emerging Companies
    • EuretinaAI: AI in Retina
    • Special Focus Meeting 2027 – Inherited Retinal Diseases
    • Special Focus Meeting 2026 – AI in Retina
      • Registration
      • Post-Event Hub
      • Hotels
      • Programme
      • Keynote
      • Poster Submission
    • Euretina 2025 Paris
      • 2025 Paris On Demand
      • Welcome
      • Congress Daily & Photo Gallery
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
      • Abstracts
      • Satellite Symposia
      • Abstract Submission
      • Late Breaking Submissions
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Euretina Innovation Spotlight (EIS)
      • General Information
        • Sustainability Plan
        • Travel Details
        • Delegate Party
        • Women in Retina Networking Breakfast
        • 2025 Press
        • Social Media Toolkit
    • Special Focus Meeting 2025 – Ocular Endotamponades
      • About
      • Programme
      • Poster & Video Presentations
    • Future Meetings
    • Upcoming Digital Events
  • Free Resources
    • Webinars
    • Podcasts
    • Case Club Cases
    • Euretina Guidelines
    • Euretina Brief
    • IME ePlatform
  • Membership
  • About
    • Euretina Board
    • Committees
    • Subspecialty Sections
    • Code of Conduct
    • Bye-laws
    • Our Sustainability Commitment
    • 25th Anniversary
      • Euretina Congresses 2001-2025
      • A History of Euretina
  • Opportunities
    • Ramin Tadayoni Award 2026
    • Mentorship Programme 2026
      • Mentorship Alumni
    • Jacqueline Cigrang AMD Research Grant
    • Observership Grant Programme 2026
    • RMCR Award Programme 2026
    • EBO-Euretina Exam 2026
    • YOURS
      • Ophthalmologica Lecturer 2026 Proposal
    • Women in Retina
      • Overview
      • Women in Retina Committee
      • Women in Retina Survey 2026
      • Women in Retina Networking Breakfast 2026
      • Women in Retina Networking Breakfast 2025
      • Interview with Anat Loewenstein
      • Women in Retina Interviews 2025
      • Women in Retina Interviews 2023
      • Euretina White Paper on Gender Diversity
      • Euretina Survey on Gender Diversity
    • BEAVRS VR Database
    • CME Credits
  • Member Login

IMPORTANT INFORMATION

Beware of fraudulent websites, emails and hotel booking offers

www.euretina.org is the only official website of the European Society of Retina Specialists.
 
Please be wary of websites, emails from third-party agencies using similar names, addresses or branding and purporting to represent Euretina.
 
This includes websites or companies offering Congress registration, hotel accommodation or travel services while claiming to be affiliated with Euretina.

Should you use any website other than www.euretina.org, or book accommodation through an unauthorised third-party site, you may be charged significantly more than the official registration fee, your hotel booking may not be valid, and you may not be registered for the event at all.
 
If you have any questions in relation to registration or accommodation for the Congress, these should only be directed to [email protected].